Does astrocyte pyroptosis help explain stress depression in mice?
In a mouse chronic-mild-stress model, hippocampal astrocytes died by NLRP3/caspase-1/GSDMD pyroptosis; knocking out that cascade (or giving an SSRI) eased depression-like behavior, while putting GSDMD-N back in astrocytes wiped out the benefit.
Source
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression
Study at a glance
- Design
- Animal / in-vitro — Mouse chronic mild stress (CMS) plus astrocyte-targeted NLRP3/Casp-1/GSDMD genetics and SSRI treatment; hippocampal pyroptosis and depression-like behavior
- N
- N=8 · Typical behavioral cohorts n = 8 mice/group; immunoblots n = 4/group; mixed WT, NLRP3-cKO, Casp-1−/−, GSDMD−/− lines
- Population
- Male C57BL/6J mice (WT, astrocytic NLRP3-cKO, Casp-1 and GSDMD knockouts) under CMS
- Outcome
- Depression-like behavior (SPT/FST) and astrocytic NLRP3/Casp-1/GSDMD pyroptosis in hippocampus
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
Exposed male C57BL/6J mice to CMS for up to 6 weeks (SPT/FST), measured hippocampal Casp-1/GSDMD/IL-1β and astrocytic pyroptosis, then used GSDMD, Casp-1, and astrocytic NLRP3 knockouts plus SSRI (fluoxetine/citalopram) and astrocytic GSDMD-N overexpression.
What they found
CMS cut sucrose preference by week 6 and raised FST immobility. Depressive mice showed astrocytic pyroptosis and astrocyte loss; SSRIs reduced that pyroptosis. Genetic KO of GSDMD, Casp-1, or astrocytic NLRP3 improved behavior and lowered pyroptosis proteins; hippocampal GSDMD-N overexpression reversed GSDMD-KO benefits.
The limits
What it doesn't show
Mouse CMS is not human MDD; targeting NLRP3/GSDMD is a mechanistic hypothesis, not a licensed antidepressant strategy, and n is small per group.
Key terms
- Pyroptosis
- Inflammatory programmed cell death driven by caspase cleavage of gasdermin D.
- NLRP3 inflammasome
- Cytosolic sensor complex that activates caspase-1; here targeted in astrocytes.
- GSDMD-N
- N-terminal fragment of gasdermin D that forms membrane pores.
- CMS
- Chronic mild stress used to induce depression-like behavior.
- SPT / FST
- Sucrose preference (anhedonia) and forced-swim (immobility) tests.
- SSRI
- Fluoxetine and citalopram; here they also reduced CMS-induced pyroptosis.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
The pyroptotic cells were mainly:
Common questions
Which cell type pyroptosed?
Astrocytes in hippocampus, via NLRP3/Casp-1/GSDMD.
Did SSRIs affect pyroptosis?
Yes—SSRI treatment attenuated CMS-induced pyroptosis.
What reversed GSDMD-KO rescue?
Overexpressing astrocytic GSDMD-N in hippocampus.
Typical n per behavior group?
n = 8 mice per group.
More on Depression